Caricamento...
来那度胺治疗复发难治性多发性骨髓瘤57例临床观察
OBJECTIVE: To investigate the clinical efficacy and safety of lenalidomide (Revlimid, R) - based chemotherapy in the treatment of relapsed/refractory multiple myeloma (MM) patients. METHODS: 57 consecutively relapsed/refractory MM patients were retrospectively analyzed from June 2013 to February 201...
Salvato in:
| Pubblicato in: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Editorial office of Chinese Journal of Hematology
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7342977/ https://ncbi.nlm.nih.gov/pubmed/28655091 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.06.005 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|